Skip to content
MedsAcross

Medicine

Fluticasone propionate 0.005% ointment

Available on requestPrescription onlyUS FDAGeneric name

Fluticasone propionate 0.005% ointment is a generic prescription medicine for topical use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20-25°C (68-77°F) Repackaged/Relabeled by: Bryant Ranch Prepack, Inc.

Key facts

Active ingredient (INN)
Fluticasone propionate
Brand
Sold under the generic name
Strength
0.005%
Dosage form
Ointment
Route
Topical
Packs
1 tube and 9 more
Manufacturers
Bryant Ranch PrepackCosette PharmaceuticalsPadagis Israel Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20-25°C (68-77°F) Repackaged/Relabeled by: Bryant Ranch Prepack, Inc.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
31 May 2006
Identifiers
RxCUI 895487DailyMed set ID 96e0681d-3788-49cc-8c0e-3185675b8da1, 16985600-3f81-4d51-8bf7-0cbbd89856a1, f6aca9a9-0310-4c11-84b2-eacd19c45a1d +3NDC 63629-8661, 45802-221, 63629-8662 +3Application ANDA076668, ANDA077168

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 tube in 1 carton / 15 g in 1 tube0713-0632-15Cosette Pharmaceuticals31 May 2006
1 tube in 1 carton / 30 g in 1 tube0713-0632-31Cosette Pharmaceuticals31 May 2006
1 tube in 1 carton / 60 g in 1 tube0713-0632-60Cosette Pharmaceuticals31 May 2006
1 tube in 1 carton / 30 g in 1 tube45802-221-11Padagis Israel Pharmaceuticals9 July 2007
1 tube in 1 carton / 15 g in 1 tube45802-221-35Padagis Israel Pharmaceuticals12 February 2008
1 tube in 1 carton / 60 g in 1 tube45802-221-37Padagis Israel Pharmaceuticals31 October 2007
1 tube in 1 carton / 15 g in 1 tube63629-8661-1Bryant Ranch Prepack12 February 2008
1 tube in 1 carton / 30 g in 1 tube63629-8662-1Bryant Ranch Prepack9 July 2007
1 tube in 1 carton / 60 g in 1 tube63629-8663-1Bryant Ranch Prepack31 October 2007
1 tube in 1 carton / 15 g in 1 tube72162-1401-2Bryant Ranch Prepack11 March 2024
1 tube in 1 carton / 30 g in 1 tube72162-1401-3Bryant Ranch Prepack11 March 2024
1 tube in 1 carton / 60 g in 1 tube72162-1401-6Bryant Ranch Prepack11 March 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 December 1990Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Fluticasone propionate

Clinical summary

Fluticasone propionate is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older, among other approved uses. MedsAcross supplies Fluticasone propionate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Fluticasone propionate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Fluticasone propionate 0.005% ointment for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.